Brooklyn ImmunoTherapeutics Announces Second Quarter 2021 Financial Results
16 août 2021 07h00 HE
|
Brooklyn Immunotherapeutics LLC
NEW YORK, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that gene editing/cell and...